Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Horizon Therapeutics, Microsoft, Gap rise premarket; Amgen, Rivian fall

Published 2022-12-12, 08:12 a/m
Updated 2022-12-12, 08:12 a/m
© Reuters.

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Monday, December 12th. Please refresh for updates.

  • Amgen (NASDAQ:AMGN) stock fell 3.2% after the Wall Street Journal reported the biopharmaceutical giant was in pole position to acquire Horizon Therapeutics (NASDAQ:HZNP), up 15%, after French rival Sanofi pulled out over the weekend.

  • Microsoft (NASDAQ:MSFT) stock rose 0.5% after the tech giant announced plans to take a 4% stake in London Stock Exchange Group, in return for a big 10-year commitment to its Azure cloud hosting service.

  • Rivian Automotive (NASDAQ:RIVN) stock fell 2.4% after the EV manufacturer suspended a project that would have seen it launch electric van making in Europe in partnership with Mercedes (ETR:MBGn).

  • Box (NYSE:BOX) stock rose 3.7% after JPMorgan upgraded its stance on the cloud-based content management provider to ‘overweight’ from ‘neutral’, saying the stock can rally 20% given its strong financials and product suite.

  • Coupa Software (NASDAQ:COUP) stock soared 26% after private equity firm Thoma Bravo agreed to buy the tech firm in a deal worth $8 billion.
  • Gap (NYSE:GPS) stock rose 3.2% and Tapestry (NYSE:TPR) stock rose 2.6% after Goldman Sachs upgraded both retailers to 'buy' from 'neutral', expecting them to thrive as customers became more discerning with their spending. On the flip side, the investment bank downgraded Levi Strauss (NYSE:LEVI), down 0.7%, to 'neutral' from 'buy'.
  • Best Buy (NYSE:BBY) stock rose 1.9% after Goldman Sachs upgraded the electronics retailer to 'neutral' from 'sell', citing the ability to maintain prices and gain market share in the difficult climate.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.